FDA Reg Failures in Enforcing Limits on GLP-1 Compounding
In recent years, U.S. Food and Drug Administration (FDA)-approved GLP-1 medicines have surged in popularity as treatments for diabetes and obesity.
Comment
Show comments
Hide Comments
